Fresenius Kabi iPSUM, a unit of the Fresenius Kabi group, applies current Best Manufacturing Practices (BMP) in its specialist manufacturing of β-lactam type active principles, for oral and sterile formulations. Approved by the FDA (Food and Drug Administration), it supplies third parties with its products that include penicillins and sterile cephalosporins such as: tazobactam, ceftriaxone, cefuroxime, cefazolin, cefotaxime, ceftazidime and also in association with sulbactam, amoxicillin, cloxacillin, dicloxacillin, flucloxacillin, nafcillin, oxacillin, mecillinam, and various associations of penicillins.
FRESENIUS KABI IPSUM
darbība
Atslēgas vārdi, kas saistās ar šo uzņēmumu
- Farmaceitiski izstrādājumi
- ANTI-INFECTIVES
- AMOXICILLIN
- active pharmaceutical ingredients
- CEFALONIUM
- CLOXACILLIN
- AMPICILLIN
- sterile cephalosporins
- CEFEPIME
- chemical products for the pharmaceutical industry
Palielināt sarakstu
Papildus informācija
Publicēt mana uzņēmuma saturus
Atslēgas ciparu
Organizācija
Apmaiņas tirgi un zonas
Komerciālā rakstura informācija
A32661920
3183 p v